1,325 ARS
15.67 T ARS
58.58 T ARS
About Merck & Company, Inc.
Sector
Industry
CEO
Robert M. Davis
Website
Headquarters
Rahway
Founded
1891
ISIN
ARDEUT110277
FIGI
BBG000FSRB61
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
AAA - Setup from the bottomInverse head and shoulders pattern on the daily timeframe and if you were to break it down further to 12hr it should be also clear.
Monthly rsi sharply bounced back below an RSI of 30, weekly rsi has been below 30 rsi for multile touches
rsi line and rsi moving average crossover indicating change i
Merck Wave Analysis – 19 May 2025
- Merck reversed from support area
- Likely to rise to resistance level 80.00
Merck recently reversed up from the support area between the long-term support level 73.35 (which has been reversing the price from the middle of 2020) and the lower weekly Bollinger Band.
The upward reversal from this
Merck & Company Potential Post Tariff Resolution Bullish RallyWith potential developments towards the resolution of global tariffs and pharma being defensive in general, MRK price action seems to exhibit signs of a potential Bullish reversal breakout as the price action may form a prominent Higher High with multiple confluences through key Fibonacci and Suppor
Buy MRK Merck being a Pharma company which belongs to a defensive sector is a good buy around 69$ levels. Has a P/E of less 10 and dividend of 4% at current price can be a good long term hold who targets passive income with dividend.
For swing trade , buying at 69-70 levels and target 20% to sell at 85 lev
Is MRK Setting Up for a Major Comeback? 🧬Merck & Co. (MRK) is trading around $81.00 down significantly from its 52-week high of $134.63 but this pullback could be your window of opportunity. With a solid forward P/E of 9.02, a 3.9% dividend yield, and a pipeline packed with over 20 potential blockbuster drugs, the fundamentals remain str
MERCK Stock Chart Fibonacci Analysis 042525Trading Idea
1) Find a FIBO slingshot
2) Check FIBO 61.80% level
3) Entry Point > 82/61.80%
Chart time frame: D
A) 15 min(1W-3M)
B) 1 hr(3M-6M)
C) 4 hr(6M-1year)
D) 1 day(1-3years)
Stock progress: A
A) Keep rising over 61.80% resistance
B) 61.80% resistance
C) 61.80% support
D) Hit the bottom
E
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
MRK5002693
Merck & Co., Inc. 2.45% 24-JUN-2050Yield to maturity
7.30%
Maturity date
Jun 24, 2050
MRK5319197
Merck & Co., Inc. 2.9% 10-DEC-2061Yield to maturity
7.17%
Maturity date
Dec 10, 2061
US58933YBF1
MERCK & CO. 21/51Yield to maturity
7.15%
Maturity date
Dec 10, 2051
US58933YBA2
MERCK & CO. 20/40Yield to maturity
6.56%
Maturity date
Jun 24, 2040
US58933YAT2
MERCK CO. 2045Yield to maturity
6.34%
Maturity date
Feb 10, 2045
MRK4806294
Merck & Co., Inc. 4.0% 07-MAR-2049Yield to maturity
6.31%
Maturity date
Mar 7, 2049
MRK3900816
Merck & Co., Inc. 3.6% 15-SEP-2042Yield to maturity
6.17%
Maturity date
Sep 15, 2042
US58933YAJ4
MERCK CO. 13/43Yield to maturity
6.16%
Maturity date
May 18, 2043
MRK5584756
Merck & Co., Inc. 5.15% 17-MAY-2063Yield to maturity
6.03%
Maturity date
May 17, 2063
MRK5584755
Merck & Co., Inc. 5.0% 17-MAY-2053Yield to maturity
5.97%
Maturity date
May 17, 2053
MRK5584925
Merck & Co., Inc. 4.9% 17-MAY-2044Yield to maturity
5.78%
Maturity date
May 17, 2044
See all MRK bonds
Curated watchlists where MRK is featured.